Masafumi Ikeda, Takeshi Terashima, Tatsuya Yamashita, Takuji Okusaka, Hiroshi Imaoka, Tomokazu Kawaoka, Satoshi Kobayashi, Sadahisa Ogasawara, Atsushi Hiraoka, Masahito Nakano, Fumio Nagashima, Rie Sugimoto, Michihisa Moriguchi, Yoshitaka Inaba, Satoru Shinoda, Makoto Ueno, Naoya Kato, Masatoshi Kudo, Junji Furuse, Hiroaki Nagano. "A multicenter, phase 2 study of atezolizumab plus bevacizumab (atezo+bev) combination therapy in patients with unresectable hepatocellular carcinoma (HCC) and Child–Pugh class B cirrhosis: CHALLENGE trial final results.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.587